TELA
Tela Bio Inc
NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES
$0.87
+1.72% today
Updated 2026-04-30
Market cap
$34.90M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Tela Bio Inc (TELA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.37M | $-19.92M | $-25.52M | $-24.46M | $-30.43M | $-40.75M | $-40.86M | $-41.59M | $-28.22M |
| Capital expenditures | $114000.00 | $1.56M | $2.70M | $167000.00 | $627000.00 | $1.87M | $611000.00 | $989000.00 | $448000.00 |
| Depreciation | $761000.00 | $1.25M | $582000.00 | $525000.00 | $535000.00 | $1.19M | $808000.00 | $1.01M | — |
| Stock-based comp | $197000.00 | $216000.00 | $457000.00 | $2.06M | $3.66M | $3.99M | $5.03M | $4.36M | $3.80M |
| Free cash flow | $-16.48M | $-21.49M | $-28.22M | $-24.62M | $-31.06M | $-42.62M | $-41.47M | $-42.58M | $-28.67M |
| Investing cash flow | $-101000.00 | $-1.56M | $-11.98M | $9.12M | $-627000.00 | $-1.87M | $-599000.00 | $4.45M | — |
| Financing cash flow | $26.34M | $27.41M | $65.53M | $44.41M | $585000.00 | $40.85M | $46.27M | $43.06M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-30.47M | $-1.77M | — | — | — |